Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetic determinants of micronucleus formation in vivo.

Nature·2024

Same author

Experimental fluid dynamics characterization of a novel micropump-mixer.

Biomicrofluidics·2020

Same author

Shear-sensitive nanocapsule drug release for site-specific inhibition of occlusive thrombus formation.

Journal of thrombosis and haemostasis : JTH·2017

Same author

Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.

Journal of thrombosis and haemostasis : JTH·2016

Same author

Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.

Journal of thrombosis and haemostasis : JTH·2016

Same author

Survivability of Escherichia coli O157:H7 in mechanically tenderized beef steaks subjected to lactic acid application and cooking under simulated industry conditions.

Journal of food protection·2013

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Dynamics of platelet thrombus formation.

S P Jackson¹, W S Nesbitt, E Westein

¹The Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia. shaun.jackson@med.monash.edu.au

Journal of Thrombosis and Haemostasis : JTH

|July 28, 2009

Summary

Platelet aggregation involves biomechanical forces and soluble agonists. Understanding their interplay is key to unraveling thrombus formation in atherosclerosis and preventing blood flow obstruction.

More Related Videos

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

Related Experiment Videos

Last Updated: Jun 21, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

Area of Science:

Cardiovascular Biology
Hemostasis and Thrombosis
Biomedical Engineering

Background:

Platelet aggregation and thrombus formation are critical in atherosclerotic plaque rupture, potentially causing ischemic injury.
These processes are regulated by both biomechanical (rheological) and soluble agonist-dependent mechanisms.
The interplay between these two pathways is crucial for understanding thrombus dynamics.

Purpose of the Study:

To elucidate the dynamic interplay between rheological and soluble agonist-dependent mechanisms in platelet aggregation and thrombus formation.
To highlight the roles of key platelet adhesion receptors, GPIb and integrin alpha(IIb)beta3, in mechanotransduction.
To emphasize the importance of considering both mechanisms for a comprehensive understanding of in vivo thrombus development.

Main Methods:

Review of existing evidence on platelet aggregation dynamics.
Analysis of the roles of rheological forces and soluble agonists in platelet activation.
Examination of the function of platelet adhesion receptors (GPIb, integrin alpha(IIb)beta3) in mechanotransduction.

Main Results:

Platelet aggregation is governed by two complementary processes: rheological and soluble agonist-dependent.
Rheological-dependent aggregation relies on the mechanotransduction function of GPIb and integrin alpha(IIb)beta3.
Soluble agonists enhance platelet activation, shape change, degranulation, and stabilize aggregates.

Conclusions:

A comprehensive understanding of platelet aggregation and thrombus formation necessitates considering the cooperative interplay between rheological and soluble agonist-dependent mechanisms.
This integrated view is essential for addressing blood flow obstruction in conditions like atherosclerosis.
Further research into these combined dynamics can inform therapeutic strategies.